Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Short Interest Down 95.8% in December

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totalling 2,400 shares, a decline of 95.8% from the November 30th total of 56,900 shares. Based on an average daily trading volume, of 1,090,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.1% of the company’s shares are short sold.

Shuttle Pharmaceuticals Trading Down 7.0 %

Shares of NASDAQ:SHPH traded down $0.06 during trading on Friday, reaching $0.74. The stock had a trading volume of 76,630 shares, compared to its average volume of 428,739. Shuttle Pharmaceuticals has a fifty-two week low of $0.58 and a fifty-two week high of $4.95. The firm’s fifty day moving average is $1.02. The firm has a market cap of $2.72 million, a PE ratio of -0.18 and a beta of -1.70.

About Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .